Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedFooter now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a minor version update of the page's documentation and does not alter study details or content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision label in the footer was updated from v3.6.0 to v3.6.3, indicating a newer build/version of the page.SummaryDifference0.0%

- Check36 days agoChange DetectedRecruitment status was updated with a new note that the study is no longer looking for participants. Additional navigation and labeling updates were added, including How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with the Revision: v3.6.0 label.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.5.5 has been applied, replacing the previous Revision: v3.5.4. This represents a minor software update to the interface and does not modify any study data or displayed content.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 in the Study Documents, indicating a new version of documents is available. This reflects updated Protocol and Statistical Analysis Plan materials associated with the AbbVie study.SummaryDifference0.0%

- Check86 days agoChange DetectedThe website’s ClinicalTrials.gov footer was updated from revision v3.5.2 to v3.5.3, indicating a platform release/version update.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.